Status:
COMPLETED
Strategies Targeting Osteoporosis to Prevent Recurrent Fractures
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Osteoporosis
Fractures
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
An evidence-based quality improvement intervention will overcome multiple barriers to best practice and improve rates of diagnosis and effective treatment for osteoporosis in high-risk patients. The i...
Detailed Description
Background: Osteoporosis leads to decreased bone mass, skeletal fragility, and fractures. Fractures cause disability, deformity, and even death. Osteoporosis affects 1.4 million Canadians, 25% of wome...
Eligibility Criteria
Inclusion
- All patients 50 years of age or older with a wrist fracture who present to the Emergency Departments or Fracture Clinics at our two study sites will be eligible for study enrollment. Specifically:
- Age 50 years or greater,
- Any distal forearm fracture
Exclusion
- Unable to give simple informed consent,
- Unwilling to participate in the study,
- Unable to understand, read, or converse in English,
- Place of residence outside Capital Health or longterm care facility,
- Already receiving osteoporosis treatment with a bisphosphonate,
- Previously documented allergy or intolerance to a bisphosphonate,
- Currently enrolled in the pilot study or other osteoporosis study
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
242 Patients enrolled
Trial Details
Trial ID
NCT00152321
Start Date
September 1 2003
End Date
March 1 2010
Last Update
July 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada, T6G 2B7